The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.

Saved in:
Bibliographic Details
Title: The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.
Authors: Gormley JA; Fusion Antibodies Ltd, Springbank Industrial Estate, Pembroke Loop Rd, Belfast BT17 0QL, Northern Ireland. julie.gormley@fusionantibodies.com, Hegarty SM, O'Grady A, Stevenson MR, Burden RE, Barrett HL, Scott CJ, Johnston JA, Wilson RH, Kay EW, Johnston PG, Olwill SA
Source: British journal of cancer [Br J Cancer] 2011 Nov 08; Vol. 105 (10), pp. 1487-94. Date of Electronic Publication: 2011 Oct 11.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/bjc.2011.408